Alumis Inc.
ALMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847367
In the last 90 days, Alumis Inc. insiders filed 1 open-market purchase and 8 sales; 198 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Alumis Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +29 vs. Q1 2024
- Shares held
- 28.6M
- +28.6M vs. Q1 2024
- Total value
- $380.0M
- +$380.0M vs. Q1 2024
- New holders
- 29
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 198 | $3.32B |
| Q1 2026 | 197 | $2.53B |
| Q4 2025 | 134 | $771.1M |
| Q3 2025 | 130 | $311.2M |
| Q2 2025 | 112 | $235.0M |
| Q1 2025 | 72 | $246.8M |
| Q4 2024 | 64 | $316.5M |
| Q3 2024 | 52 | $376.1M |
| Q2 2024 | 29 | $380.0M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Alumis Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Salem Investment Counselors Inc | 20 | $266 | 0.00% | +20 | New |
| Weiss Asset Management LP | 10,000 | $133.0K | 0.01% | +10,000 | New |
| Jane Street Group, LLC | 10,155 | $135.1K | 0.00% | +10,155 | New |
| Eisler Capital (US) LLC | 10,746 | $142.9K | 0.03% | +10,746 | New |
| Fifth Lane Capital, LP | 13,000 | $172.9K | 0.38% | +13,000 | New |
| Landscape Capital Management, L.L.C. | 16,078 | $213.8K | 0.02% | +16,078 | New |
| Two Sigma Investments, LP | 19,000 | $252.7K | 0.00% | +19,000 | New |
| Balyasny Asset Management LLC | 20,000 | $266.0K | 0.00% | +20,000 | New |
| Citadel Advisors LLC | 20,922 | $278.3K | 0.00% | +20,922 | New |
| HRT Financial LP | 21,150 | $281.0K | 0.00% | +21,150 | New |
| Polygon Management Ltd. | 24,350 | $323.9K | 0.10% | +24,350 | New |
| Maven Securities LTD | 25,000 | $332.5K | 0.05% | +25,000 | New |
| Hudson Bay Capital Management LP | 37,500 | $498.8K | 0.00% | +37,500 | New |
| Vanguard Group Inc | 120,000 | $1.60M | 0.00% | +120,000 | New |
| Sphera Funds Management Ltd. | 125,000 | $1.66M | 0.27% | +125,000 | New |
| Iron Triangle Partners LP | 125,000 | $1.66M | 0.17% | +125,000 | New |
| Norges Bank | 250,000 | $3.33M | 0.00% | +250,000 | New |
| Millennium Management LLC | 253,820 | $3.38M | 0.00% | +253,820 | New |
| Towerview LLC | 310,000 | $4.12M | 2.70% | +310,000 | New |
| Morgan Stanley | 375,000 | $4.99M | 0.00% | +375,000 | New |
| Ally Bridge Group (NY) LLC | 618,750 | $8.23M | 4.90% | +618,750 | New |
| Omega Fund Management, LLC | 653,225 | $8.69M | 6.44% | +653,225 | New |
| Fan Yu | 789,618 | $10.5M | 13.72% | +789,618 | New |
| Baker Bros. Advisors LP | 1,562,500 | $20.8M | 0.27% | +1,562,500 | New |
| Sr One Capital Management, LP | 1,959,896 | $26.1M | 8.16% | +1,959,896 | New |
| Cormorant Asset Management, LP | 2,147,400 | $28.6M | 1.66% | +2,147,400 | New |
| venBio Partners LLC | 2,826,048 | $37.6M | 16.23% | +2,826,048 | New |
| Foresite Capital Management V, LLC | 5,584,887 | $74.3M | 47.43% | +5,584,887 | New |
| AyurMaya Capital Management Company, LP | 10,645,965 | $141.6M | 77.47% | +10,645,965 | New |